ENSC logo

Ensysce Biosciences, Inc.

ENSC
Healthcare|Biotechnology|US
$0.33
-0.03 (-8.95%)
DCF Value
$0.06
Cash / Share
$0.05
Next Earnings Report
Nov 13, 2026
EPS est. -$0.12 · Revenue est. $1.2M
Financing Filings (last 12 months)
5
Shelf registrations / offering prospectuses — latest Oct 23, 2026 (S-3). Possible dilution.

Upcoming Data Readouts (1)

Dec 2026
Est. completion
P1Pharmacokinetics
Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)
NCT06500793n=54

Recent Press Releases

Ensysce Biosciences Expands Global Investor and Strategic Outreach at Family Office Summit, Dubai
Oct 21, 2026 · Accesswire
Ensysce Biosciences Phase 2 Protocol for CY200 - A Neuroplastigen for the Treatment of CRPS - Submitted to the UK MHRA
Sep 24, 2026 · Accesswire
Ensysce Biosciences Advances CRPS Program at Painweek 2026, Contributes to FDA Hearing on Psychedelic Drug Regulation
Sep 15, 2026 · Accesswire
Ensysce Biosciences' Professor Richard Langford Selected to Speak at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs
Sep 14, 2026 · Accesswire
Ensysce Biosciences Announces Upcoming Conference and Industry Event Participation
Sep 2, 2026 · Accesswire
Ensysce Biosciences Completes Final Phase of PF614-MPAR-102 Clinical Study
Aug 31, 2026 · Accesswire
Ensysce Biosciences to Showcase "A New Era in Pain Therapeutics" at PAINWeek 2026 Symposium
Aug 20, 2026 · Accesswire
Ensysce Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Aug 13, 2026 · Accesswire

SEC Filings (74)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 4, 20268-KMaterial eventDocumentIndex
Oct 30, 2026PRE 14AProxy / shareholder voteDocumentIndex
Oct 23, 2026S-3Shelf registrationDocumentIndex
Oct 16, 20268-K/AMaterial eventDocumentIndex
Sep 29, 20268-KMaterial eventDocumentIndex
Aug 25, 20268-KMaterial eventDocumentIndex
Aug 24, 20268-KMaterial eventDocumentIndex
Aug 20, 2026DDocumentIndex
Aug 18, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Aug 13, 202610-QQuarterly reportDocumentIndex
Aug 13, 20268-KMaterial eventDocumentIndex
Aug 6, 20268-K/AMaterial eventDocumentIndex
Aug 6, 20268-KMaterial eventDocumentIndex
Jul 15, 20268-KMaterial eventDocumentIndex
Jun 26, 2026EFFECTDocumentIndex
Jun 4, 2026S-3Shelf registrationDocumentIndex
May 22, 20268-KMaterial eventDocumentIndex
May 15, 202610-QQuarterly reportDocumentIndex
May 15, 20268-KMaterial eventDocumentIndex
Apr 30, 2026S-8Employee stock planDocumentIndex
Apr 15, 2026EFFECTDocumentIndex
Apr 9, 2026S-3Shelf registrationDocumentIndex
Apr 8, 20268-KMaterial eventDocumentIndex
Apr 3, 20268-KMaterial eventDocumentIndex
Mar 30, 202610-KAnnual reportDocumentIndex
Mar 30, 20268-KMaterial eventDocumentIndex
Mar 30, 20268-KMaterial eventDocumentIndex
Mar 23, 20268-KMaterial eventDocumentIndex
Feb 27, 20268-KMaterial eventDocumentIndex
Jan 8, 20268-KMaterial eventDocumentIndex
Dec 16, 2025DEFA14AProxy / shareholder voteDocumentIndex
Dec 11, 2025EFFECTDocumentIndex
Dec 2, 2025S-3Shelf registrationDocumentIndex
Dec 2, 2025ARSAnnual report to holdersDocumentIndex
Dec 2, 2025DEF 14AProxy / shareholder voteDocumentIndex
Nov 21, 2025PRE 14AProxy / shareholder voteDocumentIndex
Nov 17, 20258-KMaterial eventDocumentIndex
Nov 14, 202510-QQuarterly reportDocumentIndex
Nov 14, 20258-KMaterial eventDocumentIndex
Nov 14, 2025424B5Offering prospectusDocumentIndex